The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 21, 2025
Filed:
Sep. 12, 2023
Merck Sharp & Dohme Llc, Rahway, NJ (US);
Yeon-Hee Lim, South San Francisco, CA (US);
Jianming Bao, Princeton, NJ (US);
Fa-Xiang Ding, Staten Island, NY (US);
Cedric Lorenz Hugelshofer, Oakland, CA (US);
Victor W. Mak, South San Francisco, CA (US);
James Patrick Roane, Brisbane, CA (US);
Jillian R. Sanzone, San Francisco, CA (US);
Samantha E. Shockley, San Francisco, CA (US);
Rose Yen, San Francisco, CA (US);
Merck Sharp & Dohme LLC, Rahway, NJ (US);
Abstract
Invented are compounds of formula I and the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are DGAT2 inhibitors. Also provided are methods of making compounds of Formula I, pharmaceutical compositions comprising compounds of Formula I, and methods of using these compounds to treat hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, type-2 diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cognitive decline, dementia, cardiorenal diseases such as chronic kidney diseases and heart failure and related diseases and conditions, comprising administering a compound of Formula I to a patient in need thereof.